Orthopedic Soft Tissue Repair Market Report 2026

The orthopedic soft tissue repair market size has grown strongly in recent years. It will grow from $6.52 billion in 2025 to $7.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to high prevalence of sports-related soft tissue injuries, limited availability of advanced soft tissue repair techniques, increasing incidence of musculoskeletal injuries in aging population, early adoption of open surgical procedures, growing demand for improved surgical outcomes.

The orthopedic soft tissue repair market size is expected to see strong growth in the next few years. It will grow to $9.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising preference for minimally invasive techniques, increasing use of biologics and regenerative therapies, expanding hospital and orthopedic clinic infrastructure, growing investment in surgical robotics and simulation, increasing focus on patient-specific repair and rehabilitation protocols. Major trends in the forecast period include rising adoption of minimally invasive soft tissue repair procedures, increasing use of biologic scaffolds and growth factors, growing integration of robotic assistance in soft tissue surgeries, rising focus on accelerated recovery and rehabilitation programs, increasing investment in surgeon training and surgical simulation.

The rising incidence of sports-related injuries is expected to drive the growth of the orthopedic soft tissue repair market in the coming years. Sports injuries occur during participation in athletic or exercise activities and can affect muscles, blood vessels, fibrous tissues, and other supporting connective tissues. Orthopedic soft tissue repair addresses these injuries, promoting healing and restoring function. For example, in July 2025, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023-24, approximately 62,100 sports injuries resulted in hospital admissions in Australia. Males accounted for 70% of hospitalizations (43,800 cases), while females accounted for about 30% (18,300 cases). Therefore, the surge in sports-related injuries is fueling growth in the orthopedic soft tissue repair market.

Companies in the orthopedic soft tissue repair market are focusing on technological innovations, such as dynamic soft tissue stabilization systems, to improve surgical outcomes and support physiological ligament motion. These systems use flexible constructs to allow controlled micromotion while securing ligaments, closely mimicking natural biomechanics and supporting biological healing, unlike rigid screw-based fixation devices that may limit movement and require removal. For instance, in September 2024, Paragon 28, Inc., a U.S.-based medical device company, launched the R3FLEX Stabilization System. This system is designed for the anatomical repair of ankle syndesmotic injuries following fractures or high ankle sprains. It combines a titanium fibular component with a tibial all-suture anchor connected by a short suture loop and a thermoplastic polyurethane (TPU) bumper, allowing controlled micromotion while providing initial stability. It also features a turn-handle mechanism for intraoperative tension adjustment and visualization, supporting a wide range of patient anatomies.

In June 2024, Stryker, a US-based medical equipment manufacturer, acquired Artelon for an undisclosed amount. This acquisition strengthens Stryker’s portfolio in joint preservation and soft tissue reconstruction. Artelon specializes in biomaterials for soft tissue reinforcement and repair, particularly for sports medicine and extremities procedures. The Georgia-based company develops innovative products designed to enhance the healing and reconstruction of ligaments and tendons.

Major companies operating in the orthopedic soft tissue repair market are Arthrex Inc., DePuy Synthes Inc. Johnson & Johnson, Stryker Corporation, Wright Medical Group N V, Zimmer Biomet, CONMED Corporation, Integra LifeSciences Holding Corporation, Smith & Nephew plc, LifeNet Health, MTF Biologics, Tissue Regenix Group plc, Bioventus Inc., Mitek Corporation, Aesculap AG & Co KG, OsteoMed Ltd., Exactech Inc., Medtronic plc, RTI Surgical Holdings Inc., Acera Surgical Inc., AlloSource, Orthofix International NV, Parcus Medical LLC, Breg Inc.

North America was the largest region in the orthopedic soft tissue repair market in 2025. The regions covered in the orthopedic soft tissue repair market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic soft tissue repair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the orthopedic soft tissue repair market by increasing the cost of imported surgical instruments, biologic scaffolds, robotic devices, and imaging equipment. Hospitals, ambulatory centers, and orthopedic clinics in north america, europe, and asia-pacific are most affected due to reliance on cross-border medical technology supply chains. Higher tariffs have raised procedural costs and delayed procurement cycles. However, tariffs have also encouraged domestic manufacturing, innovation in locally produced surgical tools, and stronger regional supply chain resilience.

The orthopedic soft tissue repair market research report is one of a series of new reports that provides orthopedic soft tissue repair market statistics, including orthopedic soft tissue repair industry global market size, regional shares, competitors with a orthopedic soft tissue repair market share, detailed orthopedic soft tissue repair market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic soft tissue repair industry. This orthopedic soft tissue repair market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Orthopedic soft tissue repair is the process of restoring injured or damaged tissues with healthy ones. This includes nerves, ligaments, blood vessels, muscles, tendons, and synovial membranes. Such injuries often occur during sports or physical activities but can also result from everyday tasks or repetitive use of a body part.

The main procedures in orthopedic soft tissue repair include cruciate ligament repair, rotator cuff repair, lateral epicondylitis treatment, Achilles tendinosis repair, pelvic organ prolapse repair, gluteal tendon repair, hip arthroscopy, biceps tenodesis, and others. Cruciate ligament repair is a surgical procedure that replaces the anterior cruciate ligament in the knee with a tissue graft to restore function after injury. Common injury sites include the knee, shoulder, hip, and small joints. End users include hospitals, ambulatory surgical centers, and orthopedic clinics.

The orthopedic soft tissue repair market includes revenues earned by entities by providing vaginal prolapse, meniscal repair, and shoulder labrum procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.